Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Chapiro

Showing results (11-20 of 167) with videos related to

Pageof 17
Sort By:
Radiology|July 24, 2015
Science to Practice: The Changing Face of Local Tumor Therapies-Do We Have to Think Systemically When Treating Cancer Locally?Julius Chapiro, Jean-François Geschwind
Radiology. Artificial Intelligence|February 21, 2020
From Code to Bedside: Introducing Predictive Intelligence to Interventional OncologyJulius Chapiro, James S Duncan
Nature Reviews. Gastroenterology & Hepatology|May 7, 2014
Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC?Julius Chapiro, Jean-François Geschwind
Seminars in Interventional Radiology|December 17, 2020
Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical PracticeNathan X Chai, Julius Chapiro
Cardiovascular and Interventional Radiology|March 18, 2025
Commentary on: Comparative Analysis of Systemic Immune Responses and Metastatic Risks in Tumor Ablation: An Animal Study of Radiofrequency Ablation and Irreversible Electroporation with Immune ModulationJessica Gois Santana, Julius Chapiro
Radiology|July 19, 2016
Science to Practice: Systemic Implications of Ablative Tumor Therapies-Reality Uncovered and Myths Exposed?Julius Chapiro, Jean-François Geschwind
Journal of the American College of Radiology : JACR|January 23, 2021
Cost-Effectiveness of Imaging Tumor Response Criteria in Hepatocellular Cancer After Transarterial ChemoembolizationXiao Wu, Julius Chapiro, Ajay Malhotra
Chinese Clinical Oncology|April 6, 2015
Percutaneous therapies of hepatocellular carcinoma-an updateJulius Chapiro, Jean-François Henri Geschwind
Clinical Advances in Hematology & Oncology : H&O|August 4, 2016
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinomaJean-Francois H Geschwind, Julius Chapiro
Gastroenterology & Hepatology|December 6, 2016
Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular CarcinomaJean-Francois H Geschwind, Julius Chapiro
Pageof 17

Showing results (11-20 of 167) with videos related to

Sort By:
Pageof 17
Radiology|July 24, 2015
Science to Practice: The Changing Face of Local Tumor Therapies-Do We Have to Think Systemically When Treating Cancer Locally?Julius Chapiro, Jean-François Geschwind
Radiology. Artificial Intelligence|February 21, 2020
From Code to Bedside: Introducing Predictive Intelligence to Interventional OncologyJulius Chapiro, James S Duncan
Nature Reviews. Gastroenterology & Hepatology|May 7, 2014
Hepatocellular carcinoma: have we finally found the ultimate staging system for HCC?Julius Chapiro, Jean-François Geschwind
Seminars in Interventional Radiology|December 17, 2020
Therapy of Intermediate-Stage Hepatocellular Carcinoma: Current Evidence and Clinical PracticeNathan X Chai, Julius Chapiro
Cardiovascular and Interventional Radiology|March 18, 2025
Commentary on: Comparative Analysis of Systemic Immune Responses and Metastatic Risks in Tumor Ablation: An Animal Study of Radiofrequency Ablation and Irreversible Electroporation with Immune ModulationJessica Gois Santana, Julius Chapiro
Radiology|July 19, 2016
Science to Practice: Systemic Implications of Ablative Tumor Therapies-Reality Uncovered and Myths Exposed?Julius Chapiro, Jean-François Geschwind
Journal of the American College of Radiology : JACR|January 23, 2021
Cost-Effectiveness of Imaging Tumor Response Criteria in Hepatocellular Cancer After Transarterial ChemoembolizationXiao Wu, Julius Chapiro, Ajay Malhotra
Chinese Clinical Oncology|April 6, 2015
Percutaneous therapies of hepatocellular carcinoma-an updateJulius Chapiro, Jean-François Henri Geschwind
Clinical Advances in Hematology & Oncology : H&O|August 4, 2016
Sorafenib in combination with transarterial chemoembolization for the treatment of hepatocellular carcinomaJean-Francois H Geschwind, Julius Chapiro
Gastroenterology & Hepatology|December 6, 2016
Sorafenib in Combination With Transarterial Chemoembolization for the Treatment of Hepatocellular CarcinomaJean-Francois H Geschwind, Julius Chapiro
Pageof 17